|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 7/12/13 China-Biotics, Inc 10-K 3/31/13 178:12M Toppan Merrill/FA |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 820K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 46K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 46K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 42K
5: EX-32.2 Certification -- §906 - SOA'02 HTML 42K
172: R1 Document And Entity Information HTML 72K
106: R2 Consolidated Balance Sheets HTML 149K
99: R3 Consolidated Balance Sheets [Parenthetical] HTML 65K
23: R4 Consolidated Statements of Operations and Other HTML 118K
Comprehensive Income
103: R5 Consolidated Statements of Changes in HTML 60K
Stockholders' Equity
67: R6 Consolidated Statements of Changes in HTML 42K
Stockholders' Equity [Parenthetical]
142: R7 Consolidated Statements of Cash Flows HTML 132K
70: R8 Organization and Description of Business HTML 52K
78: R9 Summary of Principal Accounting Policies HTML 113K
24: R10 Earnings Per Share HTML 78K
73: R11 Risks, Uncertainties, and Concentrations HTML 51K
141: R12 Accounts Receivable HTML 55K
132: R13 Inventories HTML 58K
100: R14 Loan Receivable HTML 47K
165: R15 Deposits HTML 65K
138: R16 Land Use Rights HTML 71K
20: R17 Property, Plant and Equipment HTML 76K
31: R18 Amount Due to Director HTML 46K
164: R19 Loans Payable HTML 78K
170: R20 Income Taxes Payable HTML 173K
174: R21 Treasury Stock HTML 46K
168: R22 Capital and Statutory Reserves HTML 45K
119: R23 Option Incentive Plan HTML 91K
25: R24 Product Return Concessions HTML 46K
65: R25 Retirement Costs HTML 53K
42: R26 Commitments and Contingencies HTML 72K
41: R27 Business Segments HTML 126K
80: R28 Schedule I - Condensed Parent Company Financial HTML 189K
Statements
118: R29 Summary of Principal Accounting Policies HTML 176K
(Policies)
135: R30 Summary of Principal Accounting Policies (Tables) HTML 68K
51: R31 Earnings Per Share (Tables) HTML 74K
81: R32 Accounts Receivable (Tables) HTML 55K
152: R33 Inventories (Tables) HTML 56K
46: R34 Deposits (Tables) HTML 60K
129: R35 Land Use Rights (Tables) HTML 70K
130: R36 Property, Plant and Equipment (Tables) HTML 68K
86: R37 Loans Payable (Tables) HTML 61K
40: R38 Income Taxes Payable (Tables) HTML 172K
126: R39 Option Incentive Plan (Tables) HTML 85K
49: R40 Retirement Costs (Tables) HTML 51K
79: R41 Commitments and Contingencies (Tables) HTML 51K
137: R42 Business Segments (Tables) HTML 124K
60: R43 Organization and Description of Business (Details HTML 67K
Textual)
120: R44 Summary of Principal Accounting Policies (Details) HTML 47K
98: R45 Summary of Principal Accounting Policies (Details HTML 46K
1)
45: R46 Summary of Principal Accounting Policies (Details HTML 65K
Textual)
147: R47 Earnings Per Share (Details) HTML 66K
36: R48 Earnings Per Share (Details Textual) HTML 44K
50: R49 Risks, Uncertainties, and Concentrations (Details HTML 44K
Textual)
97: R50 Accounts Receivable (Details) HTML 49K
110: R51 Inventories (Details) HTML 50K
145: R52 Loan Receivable (Details Textual) HTML 57K
21: R53 Deposits (Details) HTML 51K
124: R54 Deposits (Details Textual) HTML 55K
91: R55 Land Use Rights (Details) HTML 46K
29: R56 Land Use Rights (Details 1) HTML 58K
39: R57 Land Use Rights (Details Textual) HTML 54K
104: R58 Property, Plant and Equipment (Details) HTML 53K
159: R59 Property, Plant and Equipment (Details Textual) HTML 64K
178: R60 Loans Payable (Details) HTML 52K
176: R61 Loans Payable (Details Textual) HTML 81K
133: R62 Income Taxes Payable (Details) HTML 45K
59: R63 Income Taxes Payable (Details 1) HTML 51K
54: R64 Income Taxes Payable (Details 2) HTML 69K
125: R65 Income Taxes Payable (Details 3) HTML 60K
157: R66 Income Taxes Payable (Details 4) HTML 56K
27: R67 Income Taxes Payable (Details 5) HTML 49K
167: R68 Income Taxes Payable (Details Textual) HTML 79K
61: R69 Treasury Stock (Details Textual) HTML 54K
87: R70 Capital and Statutory Reserves (Details Textual) HTML 45K
82: R71 Option Incentive Plan (Details) HTML 62K
57: R72 Option Incentive Plan (Details 1) HTML 54K
74: R73 Option Incentive Plan (Details Textual) HTML 75K
140: R74 Product Return Concessions (Details Textual) HTML 46K
115: R75 Retirement Costs (Details) HTML 42K
15: R76 Commitments and Contingencies (Details) HTML 49K
121: R77 Commitments and Contingencies (Details Textual) HTML 64K
18: R78 Business Segments (Details) HTML 61K
112: R79 Business Segments (Details 1) HTML 55K
37: R80 Schedule I - Condensed Parent Company Financial HTML 98K
Statements (Details)
155: R81 Schedule I - Condensed Parent Company Financial HTML 90K
Statements (Details1)
148: R82 Schedule I - Condensed Parent Company Financial HTML 86K
Statements (Details2)
95: XML IDEA XML File -- Filing Summary XML 181K
175: XML.R1 Document And Entity Information XML 219K
76: XML.R2 Consolidated Balance Sheets XML 378K
117: XML.R3 Consolidated Balance Sheets [Parenthetical] XML 140K
94: XML.R4 Consolidated Statements of Operations and Other XML 321K
Comprehensive Income
90: XML.R5 Consolidated Statements of Changes in XML 450K
Stockholders' Equity
16: XML.R6 Consolidated Statements of Changes in XML 63K
Stockholders' Equity [Parenthetical]
108: XML.R7 Consolidated Statements of Cash Flows XML 388K
13: XML.R8 Organization and Description of Business XML 66K
58: XML.R9 Summary of Principal Accounting Policies XML 130K
84: XML.R10 Earnings Per Share XML 96K
71: XML.R11 Risks, Uncertainties, and Concentrations XML 64K
63: XML.R12 Accounts Receivable XML 71K
149: XML.R13 Inventories XML 75K
75: XML.R14 Loan Receivable XML 61K
169: XML.R15 Deposits XML 81K
113: XML.R16 Land Use Rights XML 88K
109: XML.R17 Property, Plant and Equipment XML 93K
116: XML.R18 Amount Due to Director XML 60K
48: XML.R19 Loans Payable XML 94K
102: XML.R20 Income Taxes Payable XML 202K
134: XML.R21 Treasury Stock XML 60K
139: XML.R22 Capital and Statutory Reserves XML 60K
151: XML.R23 Option Incentive Plan XML 110K
83: XML.R24 Product Return Concessions XML 61K
35: XML.R25 Retirement Costs XML 68K
162: XML.R26 Commitments and Contingencies XML 83K
114: XML.R27 Business Segments XML 150K
163: XML.R28 Schedule I - Condensed Parent Company Financial XML 225K
Statements
26: XML.R29 Summary of Principal Accounting Policies XML 278K
(Policies)
131: XML.R30 Summary of Principal Accounting Policies (Tables) XML 91K
128: XML.R31 Earnings Per Share (Tables) XML 93K
34: XML.R32 Accounts Receivable (Tables) XML 71K
166: XML.R33 Inventories (Tables) XML 73K
32: XML.R34 Deposits (Tables) XML 77K
171: XML.R35 Land Use Rights (Tables) XML 92K
156: XML.R36 Property, Plant and Equipment (Tables) XML 86K
146: XML.R37 Loans Payable (Tables) XML 79K
150: XML.R38 Income Taxes Payable (Tables) XML 224K
93: XML.R39 Option Incentive Plan (Tables) XML 110K
68: XML.R40 Retirement Costs (Tables) XML 67K
173: XML.R41 Commitments and Contingencies (Tables) XML 67K
127: XML.R42 Business Segments (Tables) XML 153K
161: XML.R43 Organization and Description of Business (Details XML 346K
Textual)
33: XML.R44 Summary of Principal Accounting Policies (Details) XML 153K
111: XML.R45 Summary of Principal Accounting Policies (Details XML 149K
1)
64: XML.R46 Summary of Principal Accounting Policies (Details XML 147K
Textual)
107: XML.R47 Earnings Per Share (Details) XML 152K
96: XML.R48 Earnings Per Share (Details Textual) XML 93K
52: XML.R49 Risks, Uncertainties, and Concentrations (Details XML 72K
Textual)
122: XML.R50 Accounts Receivable (Details) XML 80K
55: XML.R51 Inventories (Details) XML 88K
69: XML.R52 Loan Receivable (Details Textual) XML 164K
19: XML.R53 Deposits (Details) XML 102K
144: XML.R54 Deposits (Details Textual) XML 277K
158: XML.R55 Land Use Rights (Details) XML 78K
44: XML.R56 Land Use Rights (Details 1) XML 120K
47: XML.R57 Land Use Rights (Details Textual) XML 184K
22: XML.R58 Property, Plant and Equipment (Details) XML 244K
160: XML.R59 Property, Plant and Equipment (Details Textual) XML 314K
88: XML.R60 Loans Payable (Details) XML 167K
77: XML.R61 Loans Payable (Details Textual) XML 841K
72: XML.R62 Income Taxes Payable (Details) XML 171K
153: XML.R63 Income Taxes Payable (Details 1) XML 82K
123: XML.R64 Income Taxes Payable (Details 2) XML 141K
38: XML.R65 Income Taxes Payable (Details 3) XML 221K
56: XML.R66 Income Taxes Payable (Details 4) XML 149K
66: XML.R67 Income Taxes Payable (Details 5) XML 82K
28: XML.R68 Income Taxes Payable (Details Textual) XML 399K
62: XML.R69 Treasury Stock (Details Textual) XML 153K
101: XML.R70 Capital and Statutory Reserves (Details Textual) XML 66K
12: XML.R71 Option Incentive Plan (Details) XML 145K
136: XML.R72 Option Incentive Plan (Details 1) XML 118K
105: XML.R73 Option Incentive Plan (Details Textual) XML 256K
30: XML.R74 Product Return Concessions (Details Textual) XML 78K
143: XML.R75 Retirement Costs (Details) XML 62K
53: XML.R76 Commitments and Contingencies (Details) XML 74K
85: XML.R77 Commitments and Contingencies (Details Textual) XML 323K
154: XML.R78 Business Segments (Details) XML 354K
89: XML.R79 Business Segments (Details 1) XML 166K
177: XML.R80 Schedule I - Condensed Parent Company Financial XML 471K
Statements (Details)
43: XML.R81 Schedule I - Condensed Parent Company Financial XML 352K
Statements (Details1)
17: XML.R82 Schedule I - Condensed Parent Company Financial XML 344K
Statements (Details2)
92: EXCEL IDEA Workbook of Financial Reports (.xls) XLS 1.48M
6: EX-101.INS XBRL Instance -- chbt-20130331 XML 2.01M
8: EX-101.CAL XBRL Calculations -- chbt-20130331_cal XML 162K
9: EX-101.DEF XBRL Definitions -- chbt-20130331_def XML 797K
10: EX-101.LAB XBRL Labels -- chbt-20130331_lab XML 995K
11: EX-101.PRE XBRL Presentations -- chbt-20130331_pre XML 992K
7: EX-101.SCH XBRL Schema -- chbt-20130331 XSD 226K
14: ZIP XBRL Zipped Folder -- 0001144204-13-039226-xbrl Zip 166K
| <?xml version="1.0" encoding="windows-1252"?> | |||||||||||||||||||||
| <InstanceReport xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"> | |||||||||||||||||||||
| <Version> 2.4.0.8 </Version> | |||||||||||||||||||||
| <ReportLongName> 108 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS </ReportLongName> | |||||||||||||||||||||
| <DisplayLabelColumn> true </DisplayLabelColumn> | |||||||||||||||||||||
| <ShowElementNames> false </ShowElementNames> | |||||||||||||||||||||
| <RoundingOption/> | |||||||||||||||||||||
| <HasEmbeddedReports> false </HasEmbeddedReports> | |||||||||||||||||||||
| <Columns> | |||||||||||||||||||||
| <Column FlagID="0"> | |||||||||||||||||||||
| <Id> 1 </Id> | |||||||||||||||||||||
| <IsAbstractGroupTitle> false </IsAbstractGroupTitle> | |||||||||||||||||||||
| <LabelSeparator> </LabelSeparator> | |||||||||||||||||||||
| <CurrencyCode/> | |||||||||||||||||||||
| <FootnoteIndexer/> | |||||||||||||||||||||
| <hasSegments> false </hasSegments> | |||||||||||||||||||||
| <hasScenarios> false </hasScenarios> | |||||||||||||||||||||
| <MCU> | |||||||||||||||||||||
| <KeyName/> | |||||||||||||||||||||
| <CurrencySymbol/> | |||||||||||||||||||||
| <contextRef> | |||||||||||||||||||||
| <ContextID> P04_01_2012To03_31_2013 </ContextID> | |||||||||||||||||||||
| <EntitySchema> http://www.sec.gov/CIK </EntitySchema> | |||||||||||||||||||||
| <EntityValue> 0001271057 </EntityValue> | |||||||||||||||||||||
| <PeriodDisplayName/> | |||||||||||||||||||||
| <PeriodType> duration </PeriodType> | |||||||||||||||||||||
| <PeriodStartDate> 2012-04-01T00:00:00 </PeriodStartDate> | |||||||||||||||||||||
| <PeriodEndDate> 2013-03-31T00:00:00 </PeriodEndDate> | |||||||||||||||||||||
| <Segments/> | |||||||||||||||||||||
| <Scenarios/> | |||||||||||||||||||||
| </contextRef> | |||||||||||||||||||||
| <UPS/> | |||||||||||||||||||||
| <CurrencyCode/> | |||||||||||||||||||||
| <OriginalCurrencyCode/> | |||||||||||||||||||||
| </MCU> | |||||||||||||||||||||
| <CurrencySymbol/> | |||||||||||||||||||||
| <Labels> | |||||||||||||||||||||
| <Label Key="CalendarSupplement" Id="0" Label="12 Months Ended"/> | |||||||||||||||||||||
| <Label Key="Calendar" Id="1" Label="Mar. 31, 2013"/> | |||||||||||||||||||||
| </Labels> | |||||||||||||||||||||
| </Column> | |||||||||||||||||||||
| </Columns> | |||||||||||||||||||||
| <Rows> | |||||||||||||||||||||
| <Row FlagID="0"> | |||||||||||||||||||||
| <Id> 1 </Id> | |||||||||||||||||||||
| <IsAbstractGroupTitle> true </IsAbstractGroupTitle> | |||||||||||||||||||||
| <LabelSeparator> </LabelSeparator> | |||||||||||||||||||||
| <Level> 1 </Level> | |||||||||||||||||||||
| <ElementName> us-gaap_AccountingPoliciesAbstract </ElementName> | |||||||||||||||||||||
| <ElementPrefix> us-gaap_ </ElementPrefix> | |||||||||||||||||||||
| <IsBaseElement> true </IsBaseElement> | |||||||||||||||||||||
| <BalanceType> na </BalanceType> | |||||||||||||||||||||
| <PeriodType> duration </PeriodType> | |||||||||||||||||||||
| <IsReportTitle> false </IsReportTitle> | |||||||||||||||||||||
| <IsSegmentTitle> false </IsSegmentTitle> | |||||||||||||||||||||
| <IsCalendarTitle> false </IsCalendarTitle> | |||||||||||||||||||||
| <IsEquityPrevioslyReportedAsRow> false </IsEquityPrevioslyReportedAsRow> | |||||||||||||||||||||
| <IsEquityAdjustmentRow> false </IsEquityAdjustmentRow> | |||||||||||||||||||||
| <IsBeginningBalance> false </IsBeginningBalance> | |||||||||||||||||||||
| <IsEndingBalance> false </IsEndingBalance> | |||||||||||||||||||||
| <IsReverseSign> false </IsReverseSign> | |||||||||||||||||||||
| <FootnoteIndexer/> | |||||||||||||||||||||
| <Cells> | |||||||||||||||||||||
| <Cell FlagID="0" ContextID="" UnitID=""> | |||||||||||||||||||||
| <Id> 1 </Id> | |||||||||||||||||||||
| <IsNumeric> false </IsNumeric> | |||||||||||||||||||||
| <IsRatio> false </IsRatio> | |||||||||||||||||||||
| <DisplayZeroAsNone> false </DisplayZeroAsNone> | |||||||||||||||||||||
| <NumericAmount> 0 </NumericAmount> | |||||||||||||||||||||
| <RoundedNumericAmount> 0 </RoundedNumericAmount> | |||||||||||||||||||||
| <NonNumbericText/> | |||||||||||||||||||||
| <FootnoteIndexer/> | |||||||||||||||||||||
| <CurrencyCode/> | |||||||||||||||||||||
| <CurrencySymbol/> | |||||||||||||||||||||
| <IsIndependantCurrency> false </IsIndependantCurrency> | |||||||||||||||||||||
| <ShowCurrencySymbol> false </ShowCurrencySymbol> | |||||||||||||||||||||
| <DisplayDateInUSFormat> false </DisplayDateInUSFormat> | |||||||||||||||||||||
| </Cell> | |||||||||||||||||||||
| </Cells> | |||||||||||||||||||||
| <ElementDataType> xbrli:stringItemType </ElementDataType> | |||||||||||||||||||||
| <SimpleDataType> string </SimpleDataType> | |||||||||||||||||||||
| <IsTotalLabel> false </IsTotalLabel> | |||||||||||||||||||||
| <UnitID> 0 </UnitID> | |||||||||||||||||||||
| <Label> Accounting Policies [Abstract] </Label> | |||||||||||||||||||||
| </Row> | |||||||||||||||||||||
| <Row FlagID="0"> | |||||||||||||||||||||
| <Id> 2 </Id> | |||||||||||||||||||||
| <IsAbstractGroupTitle> false </IsAbstractGroupTitle> | |||||||||||||||||||||
| <LabelSeparator> </LabelSeparator> | |||||||||||||||||||||
| <Level> 2 </Level> | |||||||||||||||||||||
| <ElementName> chbt_OrganizationAndDescriptionOfBusinessDisclosureTextBlockTextBlock </ElementName> | |||||||||||||||||||||
| <ElementPrefix> chbt_ </ElementPrefix> | |||||||||||||||||||||
| <IsBaseElement> false </IsBaseElement> | |||||||||||||||||||||
| <BalanceType> na </BalanceType> | |||||||||||||||||||||
| <PeriodType> duration </PeriodType> | |||||||||||||||||||||
| <IsReportTitle> false </IsReportTitle> | |||||||||||||||||||||
| <IsSegmentTitle> false </IsSegmentTitle> | |||||||||||||||||||||
| <IsCalendarTitle> false </IsCalendarTitle> | |||||||||||||||||||||
| <IsEquityPrevioslyReportedAsRow> false </IsEquityPrevioslyReportedAsRow> | |||||||||||||||||||||
| <IsEquityAdjustmentRow> false </IsEquityAdjustmentRow> | |||||||||||||||||||||
| <IsBeginningBalance> false </IsBeginningBalance> | |||||||||||||||||||||
| <IsEndingBalance> false </IsEndingBalance> | |||||||||||||||||||||
| <IsReverseSign> false </IsReverseSign> | |||||||||||||||||||||
| <PreferredLabelRole> label </PreferredLabelRole> | |||||||||||||||||||||
| <FootnoteIndexer/> | |||||||||||||||||||||
| <Cells> | |||||||||||||||||||||
| <Cell FlagID="0" ContextID="P04_01_2012To03_31_2013" UnitID=""> | |||||||||||||||||||||
| <Id> 1 </Id> | |||||||||||||||||||||
| <IsNumeric> false </IsNumeric> | |||||||||||||||||||||
| <IsRatio> false </IsRatio> | |||||||||||||||||||||
| <DisplayZeroAsNone> false </DisplayZeroAsNone> | |||||||||||||||||||||
| <NumericAmount> 0 </NumericAmount> | |||||||||||||||||||||
| <RoundedNumericAmount> 0 </RoundedNumericAmount> | |||||||||||||||||||||
| <NonNumbericText> <div style="clear:both;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; FONT-SIZE: 10pt"> <table style="clear:both;MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 0px"> <div style="clear:both;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </div> </td> <td style="WIDTH: 0.5in"> <div style="clear:both;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> <b>1.</b></div> </td> <td> <div style="clear:both;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> <b>ORGANIZATION AND DESCRIPTION OF BUSINESS</b></div> </td> </tr> </table> </div> <div style="clear:both;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="clear:both;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> China-Biotics, Inc. (sometimes referred to as “China-Biotics” or the “Company”) is engaged in the research, development, production, marketing, and distribution of probiotics products (which we sometimes refer to simply as “probiotics”), which are products that contain live microbial food supplements that beneficially affect the host by improving its intestinal microbial balance.</div> <div style="clear:both;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="clear:both;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>Corporate Organization and History</b></div> <div style="clear:both;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 45pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="clear:both;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The Company was incorporated under the name Otish Resources, Inc. in Delaware in February 2003. On March 22, 2006, the Company completed a securities exchange transaction (the “share exchange”) with Sinosmart Group Inc. (“SGI”) and the shareholders of SGI and issued to the SGI shareholders an aggregate of 15,980,000 shares of newly issued common stock in exchange for all of SGI’s ordinary shares issued and outstanding. The share exchange was treated as a recapitalization with SGI treated as the accounting acquirer, and as a result, the Company became engaged in SGI’s business operations of probiotics products.</div> <div style="clear:both;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="clear:both;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> SGI was incorporated in the British Virgin Islands on February 13, 2004. SGI’s original shareholders were Mr. Song Jinan, Ms. Yan Li, Mr. Huang Weida, and Ms. Yan Yihong (the “Original SGI Shareholders”). Until August 2005, the Original SGI Shareholders owned 99.5% of the outstanding stock of Shanghai Shining Biotechnology Co. Ltd. (“Shining”), with Shanghai Shengyuan Property Co., Ltd. (“Shengyuan”) owning the remaining 0.5% of the Shining equity.</div> <div style="clear:both;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="clear:both;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> On August 11, 2005, SGI entered into an agreement to acquire 100% of the outstanding Shining shares from the Original SGI Shareholders and Shengyuan in exchange for a total cash consideration of $2.3 million dollars (RMB 18,350,000). On August 19, 2005, the transaction was approved by the Economic and Trade Bureau of the Pudong New District, Shanghai, PRC, and in October 2005, SGI made full payment of $2.3 million dollars to the Original SGI Shareholders and Shengyuan. In December 2005, a revised business license was issued to Shining as a Wholly Owned Foreign Corporation, signifying the formal recognition of SGI as Shining’s sole shareholder by the Chinese government authorities.</div> <div style="clear:both;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="clear:both;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Also on August 11, 2005, SGI granted the Original SGI Shareholders the option to purchase an aggregate of 9,000 shares of SGI for $1.00 per share. On October 25, 2005, the Original SGI Shareholders exercised the option and purchased 9,000 shares of SGI (representing 90% of the ownership of SGI) for an aggregate of $9,000. In the share exchange, the Original SGI Shareholders exchanged 9,000 shares of SGI for 10,067,400 shares of the Company’s common stock, which represented 63% of the total of 15,980,000 shares received by all SGI shareholders in this transaction.</div> <div style="clear:both;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="clear:both;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> On December 9, 2005, SGI incorporated a wholly owned subsidiary, Growing State Limited (“GSL”), in accordance with the laws of the British Virgin Islands. On September 22, 2006, GSL established a wholly foreign-owned enterprise, Growing Bioengineering (Shanghai) Company Limited (“Growing”) in the PRC.</div> <div style="clear:both;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="clear:both;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Both Shining and Growing are manufacturers and distributors of probiotics products in the PRC.</div> <div style="clear:both;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="clear:both;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> On May 4, 2010, the Company incorporated a wholly owned subsidiary, King Treasure Group Limited (“KTG”), in accordance with the laws of the British Virgin Islands. On June 25, 2010, KTG incorporated a wholly owned subsidiary, Best Design Holdings Limited (“BDH”), in Hong Kong and BDH established a wholly foreign-owned enterprise, Growing Bio (Yangling) Company Limited (“Growing Yangling”) in the PRC. Growing Yangling commenced construction a manufacturing plant in Yangling Agricultural High-tech Industries Demonstration Zone in June 2012.</div> </div> </NonNumbericText> | |||||||||||||||||||||
| <FootnoteIndexer/> | |||||||||||||||||||||
| <CurrencyCode/> | |||||||||||||||||||||
| <CurrencySymbol/> | |||||||||||||||||||||
| <IsIndependantCurrency> false </IsIndependantCurrency> | |||||||||||||||||||||
| <ShowCurrencySymbol> false </ShowCurrencySymbol> | |||||||||||||||||||||
| <DisplayDateInUSFormat> false </DisplayDateInUSFormat> | |||||||||||||||||||||
| </Cell> | |||||||||||||||||||||
| </Cells> | |||||||||||||||||||||
| <ElementDataType> nonnum:textBlockItemType </ElementDataType> | |||||||||||||||||||||
| <SimpleDataType> na </SimpleDataType> | |||||||||||||||||||||
| <ElementDefenition> The entire disclosure for organization and description of business. </ElementDefenition> | |||||||||||||||||||||
| <ElementReferences> No definition available. </ElementReferences> | |||||||||||||||||||||
| <IsTotalLabel> false </IsTotalLabel> | |||||||||||||||||||||
| <UnitID> 0 </UnitID> | |||||||||||||||||||||
| <Label> Organization and Description Of Business Disclosure Text Block [Text Block] </Label> | |||||||||||||||||||||
| </Row> | |||||||||||||||||||||
| </Rows> | |||||||||||||||||||||
| <Footnotes/> | |||||||||||||||||||||
| <IsEquityReport> false </IsEquityReport> | |||||||||||||||||||||
| <ReportName> ORGANIZATION AND DESCRIPTION OF BUSINESS </ReportName> | |||||||||||||||||||||
| <MonetaryRoundingLevel> UnKnown </MonetaryRoundingLevel> | |||||||||||||||||||||
| <SharesRoundingLevel> UnKnown </SharesRoundingLevel> | |||||||||||||||||||||
| <PerShareRoundingLevel> UnKnown </PerShareRoundingLevel> | |||||||||||||||||||||
| <ExchangeRateRoundingLevel> UnKnown </ExchangeRateRoundingLevel> | |||||||||||||||||||||
| <HasCustomUnits> true </HasCustomUnits> | |||||||||||||||||||||
| <IsEmbedReport> false </IsEmbedReport> | |||||||||||||||||||||
| <IsMultiCurrency> false </IsMultiCurrency> | |||||||||||||||||||||
| <ReportType> Sheet </ReportType> | |||||||||||||||||||||
| <RoleURI> http://www.chn-biotics.com/role/OrganizationAndDescriptionOfBusiness </RoleURI> | |||||||||||||||||||||
| <NumberOfCols> 1 </NumberOfCols> | |||||||||||||||||||||
| <NumberOfRows> 2 </NumberOfRows> | |||||||||||||||||||||
| </InstanceReport> | |||||||||||||||||||||